Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' KAYE SB' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 166 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Harries, M; Kaye, SB
      Recent advances in the treatment of epithelial ovarian cancer

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    2. Ganly, I; Kirn, D; Eckhardt, SG; Rodriguez, GI; Soutar, DS; Otto, R; Robertson, AG; Park, O; Gulley, ML; Heise, C; VonHoff, DD; Kaye, SB
      A phase I study of Onyx-015, an ELB-attenuated adenovirus, administered intratumorally to patients with recurrent head and neck cancer (vol 6, pg 798, 2000)

      CLINICAL CANCER RESEARCH
    3. Kaye, SB
      The integration of docetaxel into first-line chemotherapy for ovarian cancer

      INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
    4. Pentheroudakis, G; O'Neill, VJ; Vasey, P; Kaye, SB
      Spontaneous acute tumour lysis syndrome in patients with metastatic germ cell tumours - Report of two cases

      SUPPORTIVE CARE IN CANCER
    5. Kaye, SB; Patterson, A
      Analyzing refractive changes after anterior segment surgery

      JOURNAL OF CATARACT AND REFRACTIVE SURGERY
    6. Propper, DJ; McDonald, AC; Man, A; Thavasu, P; Balkwill, F; Braybrooke, JP; Caponigro, F; Graf, P; Dutreix, C; Blackie, R; Kaye, SB; Ganesan, TS; Talbot, DC; Harris, AL; Twelves, C
      Phase I and pharmacokinetic study of PKC412, an inhibitor of protein kinase C

      JOURNAL OF CLINICAL ONCOLOGY
    7. Fizazi, K; Tjulandin, S; Salvioni, R; Germa-Lluch, JR; Bouzy, J; Ragan, D; Bokemeyer, C; Gerl, A; Flechon, A; de Bono, JS; Stenning, S; Horwich, A; Pont, J; Albers, P; De Giorgi, U; Bower, M; Bulanov, A; Pizzocaro, G; Aparicio, J; Nichols, CR; Theodore, C; Hartmann, JT; Schmoll, HJ; Kaye, SB; Culine, S; Droz, JP; Mahe, C
      Viable malignant cells after primary chemotherapy for disseminated nonseminomatous germ cell tumors: Prognostic factors and role of postsurgery chemotherapy-results from an international study group

      JOURNAL OF CLINICAL ONCOLOGY
    8. Bowyer, JD; Majid, MA; Ah-Fat, F; Kaye, SB; Kokai, GK; May, PL; McCormick, M
      Giant cemento-ossifying fibroma of the maxilla causing proptosis in a young patient

      JOURNAL OF PEDIATRIC OPHTHALMOLOGY & STRABISMUS
    9. Smith, A; Pennefather, PM; Kaye, SB; Hart, CA
      Fluoroquinolones - Place in ocular therapy

      DRUGS
    10. Kaye, SB; Sims, G; Willoughby, C; Field, AE; Longman, L; Brown, MC
      Modification of the tear function index and its use in the diagnosis of Sjogren's syndrome

      BRITISH JOURNAL OF OPHTHALMOLOGY
    11. Vasey, PA; Atkinson, R; Coleman, R; Crawford, M; Cruickshank, M; Eggleton, P; Fleming, D; Graham, J; Parkin, D; Paul, J; Reed, NS; Kaye, SB
      Docetaxel-carboplatin as first line chemotherapy for epithelial ovarian cancer

      BRITISH JOURNAL OF CANCER
    12. Hallet, C; Willoughby, C; Shafiq, A; Kaye, SB; Bolton-Maggs, PHB
      Pitfalls in the management of a child with mild haemophilia A and a traumatic hyphaema

      HAEMOPHILIA
    13. Khuri, FR; Nemunaitis, J; Ganly, I; Arseneau, J; Tannock, IF; Romel, L; Gore, M; Ironside, J; MacDougall, RH; Heise, C; Randlev, B; Gillenwater, AM; Bruso, P; Kaye, SB; Hong, WK; Kirn, DH
      A controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer

      NATURE MEDICINE
    14. Ganly, I; Kirn, D; Eckhardt, SG; Rodriguez, GI; Soutar, DS; Otto, R; Robertson, AG; Park, O; Gulley, ML; Heise, C; VonHoff, DD; Kaye, SB
      A Phase I study of Onyx-015, an E1B attenuated adenovirus, administered intramorally to patients with recurrent head and neck cancer (vol 6, pg 798, 2000)

      CLINICAL CANCER RESEARCH
    15. Ganly, I; Kirn, D; Eckhardt, SG; Rodriguez, GI; Soutar, DS; Otto, R; Robertson, AG; Park, O; Gulley, ML; Heise, C; Von Hoff, DD; Kaye, SB
      A Phase I study of Onyx-015, an E1B attenuated adenovirus, administered intratumorally to patients with recurrent head and neck cancer

      CLINICAL CANCER RESEARCH
    16. Kaye, SB
      Intravenous chemotherapy for ovarian cancer - the state of the art?

      INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
    17. Ganly, I; Kaye, SB
      Recurrent squamous-cell carcinoma of the head and neck: Overview of current therapy and future prospects

      ANNALS OF ONCOLOGY
    18. Patterson, A; Kaye, SB; O'Donnell, NP
      Comprehensive method of analyzing the results of photoastigmatic refractive keratectomy for the treatment of post-cataract myopic anisometropia

      JOURNAL OF CATARACT AND REFRACTIVE SURGERY
    19. Ganly, I; Soutar, DS; Kaye, SB
      Current role of gene therapy in head and neck cancer

      EUROPEAN JOURNAL OF SURGICAL ONCOLOGY
    20. Mackay, HJ; Cameron, D; Rahilly, M; Mackean, MJ; Paul, J; Kaye, SB; Brown, R
      Reduced MLH1 expression in breast tumors after primary chemotherapy predicts disease-free survival

      JOURNAL OF CLINICAL ONCOLOGY
    21. Eatock, MM; Schatzlein, A; Kaye, SB
      Tumour vasculature as a target for anticancer therapy

      CANCER TREATMENT REVIEWS
    22. Kaye, LC; Kaye, SB; Lagnado, R; Boothroyd, A; Morton, C; May, P
      Cerebral arteriovenous malformation presenting as visual deterioration in a child

      DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY
    23. Plumb, JA; Strathdee, G; Sludden, J; Kaye, SB; Brown, R
      Reversal of drug resistance in human tumor xenografts by 2 '-deoxy-5-azacytidine-induced demethylation of the hMLH1 gene promoter

      CANCER RESEARCH
    24. Kaye, SB; Baker, K; Bonshek, R; Maseruka, H; Grinfeld, E; Tullo, A; Easty, DL; Hart, CA
      Human herpesviruses in the cornea

      BRITISH JOURNAL OF OPHTHALMOLOGY
    25. Gonzalez-Martin, J; Glover, S; Dixon, S; Fryer, A; Carty, H; Smith, C; Kaye, SB; Verbov, J
      Neurofibromatosis type 1 and McCune-Albright syndrome occurring in the same patient

      BRITISH JOURNAL OF DERMATOLOGY
    26. de Bono, JS; Paul, J; Simpson, A; Anthoney, A; Kirk, D; Underwood, M; Graham, J; Kaye, SB
      Improving the outcome of salvage treatment for nonseminomatous germ cell tumours (NSGCT)

      BRITISH JOURNAL OF CANCER
    27. Boulton, A; Boyd, P; Cheng, KK; Cook, J; Gilman, EA; Lunt, D; Mahler, H; Walker, C; Wardroper, M; Darbyshire, PJ; Hill, FGH; Mann, JR; Morland, B; Raafat, F; Stevens, MCG; Ahmed, A; Amos, P; Bone, V; Bonney, S; Bray, M; Cambouropoulos, P; Cook, S; Day, N; Elkins, S; Hensel, F; Lucas, P; Pettinger, J; Pugsley, M; Ruja, E; Skinner, J; Williams, D; Braodbent, V; Williams, M; Alcock, M; Bell, K; Buchan, M; Cartwright, R; Cusack, H; Fear, N; Griffiths, S; Jarvis, J; Johnson, P; Kane, E; Law, G; Moorman, A; Prajapati, J; Roberts, P; Roman, E; Simpson, J; Sinclair, V; Staines, A; Thackrah, C; Thistlethwaite, S; Waller, B; Bailey, C; Kinsey, S; Lewis, I; Picton, S; Squire, R; Taylor, R; Beck, JM; Doran, RML; Livingston, JH; Van Hille, P; Beddis, I; Cameron, MM; Craft, A; Hale, J; Kernahan, J; Reid, M; Windebank, K; Pearson, A; Skinner, R; Marks, S; Achilles, J; Alam, S; Birch, JM; Blair, V; Buckley, B; Clarkson, M; Eden, OB; Howell, S; Kellaway, C; Lashford, L; Leeke, S; Leggett, P; Murphy, AV; O'Rorke, C; Panton, S; Paxon, J; Pots, H; Roberts, C; Rothwell, J; Stephenson, W; Whelpton, B; Caswell, M; McDowell, H; Pizer, BL; Gattamaneri, R; Brock, J; Kelsey, AM; Stevens, R; Will, A; Brennan, B; Brydon, J; Dodds, C; Findlay, E; Finucane, J; Fraser, J; Harkness, E; Heary, A; Hunter, N; Juszczak, E; Lang, M; Lapsley, E; McArthur, A; MacCalman, A; McKinney, PA; Proudfoot, K; Smith, C; Smith, K; Stockton, D; Thomson, CS; Vickers, R; Wilkie, R; King, D; Mackinlay, G; Shaw, P; Thomas, A; Wallace, H; Carachi, R; Gibson, BS; Simpson, E; Cruickshank, G; Hide, TAH; Gregor, A; Steers, AJW; Barrett, A; Hamblen, DL; Kaye, SB; Mackie, R; Allen, A; Jones, AA; Beeby, S; Bignall, V; Breeze, L; Deacon, J; MacDonald, M; Matthews, F; Meggitt, C; Peto, J; Sharpe, E; Spencer, C; Swales, J; Thorne, M; Trowbridge, P; Webster-King, J; Williams, E; Bell, BA; Johnston, FG; Marsh, HT; Uttley, D; Bartlett, J; Evans, A; Gullan, RW; Glaser, MG; Peterson, D; Southcott, BM; Cavanagh, N; Pearl, K; Scott, D; Darby, CW; Chessels, J; Evans, J; Gaze, M; Hann, IM; Harkness, W; Hayward, R; Michalski, A; Passmore, J; Phillips, M; Pritchard, J; Clark, KGA; MacDonald, EA; Neville, BGR; Robb, SA; Robinson, RO; Hardwidge, C; Padgham, N; Lobo, VJ; Keen, C; Hindmarsh, PC; Kilby, AM; Souhami, RL; Tuft, S; Thomas, RM; Ward, P; Scott, M; Hoffbrand, AV; Prentice, HG; Gutteridge, CG; Newland, AC; Brada, M; Henk, JM; Meller, S; Pinkerton, R; Jones, KP; Cannon, S; Murrell, DS; Hungerford, JL; Kingston, JE; Plowman, PN; Young, B; Ball, SE; Capps, SNJ; Davies, EG; Holmes, SJK; Carr, R; Mercer, DM; Smith, MA; Andrews, VE; Hughes, RG; Ansell, P; Baker, K; Beral, V; Black, J; Boon, S; Burge, C; Burge, F; Cliff, A; Deciaccio, D; Dorman, P; Heydon, F; Langley, N; Pelerin, M; Roemmele, J; Sayers, K; Townshend, P; Harman, S; Loftus, J; Roth, S; Lee, B; Buchdahl, R; Dunger, DB; Mitchell, C; Moncrieff, MKM; Tam, PKH; Wheeler, K; Reiser, J; Joss, V; Moir, DJ; Darmady, J; Daish, P; Liberman, MM; Al-Izzi, MS; Adams, CBT; Kerr, RSC; Teddy, PJ; Barton, CJ; Newman, CL; Gabriel, CM; O'Hea, M; Sherrin, S; Watson, A; Douek, E; Connell, JA; Kelly, S; Beswick, A; Eldridge, B; Elwood, P; Hughes, J; Phillips, M; Webb, D; Alexander, FE; Bennett-Lloyd, B; Davis, A; Dunn, R; Little, J; Longdon, S; Mitchell, M; Muir, S; Sturitis, J; Kennedy, C; Kohler, J; Lang, D; Radford, M; Foreman, N; Foot, A; Mott, M; Noblett, H; Oakhill, A; Sandeman, D; Baumer, J; Ward, P; McNinch, A; Gilbertson, N; Bosley, A; Richardson, S; Challacombe, D; French, T; Bate, L; Chilvers, CED; Faulkner, G; Hawtin, P; Jenkinson, C; Kelham, P; Mackie, I; Mackie, M; Muir, KR; O'Dwyer, J; Williams, A; Nelson, C; Howarth, C; Madi, M; Shannon, R; Forman, K; Hewitt, M; Punt, J; Walker, D; Gerrard, M; Lilleyman, JS; Vora, A; Draper, G; Harrison, C; Doll, R; Richards, S; Ayres, M; Carter, R; Dearden, SP; Hussain, A; Kennedy, J; Ravetto, P; Ruprai, A; Taylor, GM; Taylor, J; Watson, PD; Colman, SM; Greaves, MF; Price, CM; Goodhead, DT; Allen, S; Bartlett, D; Blackwell, RP; Fry, F; Maslanyj, M; Mee, T; Miles, J; Adams, G
      The United Kingdom Childhood Cancer Study: objectives, materials and methods

      BRITISH JOURNAL OF CANCER
    28. Ganly, I; Soutar, DS; Brown, R; Kaye, SB
      p53 alterations in recurrent squamous cell cancer of the head and neck refractory to radiotherapy

      BRITISH JOURNAL OF CANCER
    29. Evans, TRJ; Kaye, SB
      Vaccine therapy for cancer - fact or fiction?

      QJM-MONTHLY JOURNAL OF THE ASSOCIATION OF PHYSICIANS
    30. Vasey, PA; Kaye, SB; Morrison, R; Twelves, C; Wilson, P; Duncan, R; Thomson, AH; Murray, LS; Hilditch, TE; Murray, T; Burtles, S; Fraier, D; Frigerio, E; Cassidy, J
      Phase I clinical and pharmacokinetic study of PK1 [N-(2-hydroxypropyl)methacrylamide copolymer doxorubicin]: First member of a new class of chemotherapeutic agents - Drug-polymer conjugates

      CLINICAL CANCER RESEARCH
    31. Kaye, SB; Siddiqui, A; Ward, A; Noonan, C; Fisher, AC; Green, JR; Brown, MC; Wareing, PA; Watt, P
      Monocular and binocular depth discrimination thresholds

      OPTOMETRY AND VISION SCIENCE
    32. Wyke, JA; Finbow, ME; Graham, GJ; Barnett, SC; Schiebel, E; Campo, MS; Parkinson, EK; Ozanne, BW; Frame, MC; Kolch, W; Gillespie, DAF; Harrison, PR; Black, DM; Kaye, SB; Keith, WN; Brown, R; Brown, K; Twelves, CJ; Kaye, SB; Vasey, PA; Brown, R; Barrett, A; Wheldon, TE; Mairs, RJ
      Cover legend: The Cancer Research Campaign Beatson Laboratories, Glasgow, UK

      ONCOLOGY REPORTS
    33. Kaye, SB
      Progress in the treatment of ovarian cancer

      ANTI-CANCER DRUGS
    34. Anthoney, DA; Kaye, SB
      Treatment for poor prognosis metastatic germ-cell tumours: Much heat but, as yet, little light

      ANNALS OF ONCOLOGY
    35. Stevenson, JP; DeMaria, D; Sludden, J; Kaye, SB; Paz-Ares, L; Grochow, LB; McDonald, A; Selinger, K; Wissel, P; O'Dwyer, PJ; Twelves, C
      Phase I pharmacokinetic study of the topoisomerase I inhibitor GG211 administered as a 21-day continuous infusion

      ANNALS OF ONCOLOGY
    36. Kaye, SB; Eisenhauer, EA; Hamilton, TC
      New non-cytotoxic approaches to ovarian cancer

      ANNALS OF ONCOLOGY
    37. Hamilton, TC; Berek, JS; Kaye, SB
      Basic research: how much do we know, and what are we likely to learn aboutovarian cancer in the near future?

      ANNALS OF ONCOLOGY
    38. Piccart, MJ; Stuart, GCE; Cassidy, J; Bertelsen, K; Parmar, MKB; Eisenhauer, EA; Kaye, SB; Trope, C; Swenerton, K; Harper, P; Vermorken, JB
      Intergroup collaboration in ovarian cancer: a giant step forward

      ANNALS OF ONCOLOGY
    39. Berek, JS; Bertelsen, K; du Bois, A; Brady, MF; Carmichael, J; Eisenhauer, EA; Gore, M; Grenman, S; Hamilton, TC; Hansen, SW; Harper, PG; Horvath, G; Kaye, SB; Luck, HJ; Lund, B; McGuire, WP; Neijt, JP; Ozols, RF; Parmar, MKB; Piccart-Gebhart, MJ; van Rijswijk, R; Rosenberg, P; Rustin, GJS; Sessa, C; Thigpen, JT; Trope, C; Tuxen, MK; Vergote, I; Vermorken, JB; Willemse, PHB
      Advanced epithelial ovarian cancer: 1998 consensus statements

      ANNALS OF ONCOLOGY
    40. Vasey, PA; Paul, J; Birt, A; Junor, EJ; Reed, NS; Symonds, RP; Atkinson, R; Graham, J; Crawford, SM; Coleman, R; Thomas, H; Davis, J; Eggleton, SPH; Kaye, SB
      Docetaxel and cisplatin in combination as first-line chemotherapy for advanced epithelial ovarian cancer

      JOURNAL OF CLINICAL ONCOLOGY
    41. O'Neill, VJ; Evans, TRJ; Preston, J; Moss, J; Kaye, SB
      A retrospective analysis of Hickman line-associated complications in patients with solid tumours undergoing infusional chemotherapy

      ACTA ONCOLOGICA
    42. Sarvesvaran, J; Going, JJ; Milroy, R; Kaye, SB; Keith, WN
      Is small cell lung cancer the perfect target for anti-telomerase treatment?

      CARCINOGENESIS
    43. Kaye, SB
      Oral Tumoractivated (TM) chemotherapy - An introduction

      ONCOLOGY
    44. Kaye, SB
      Perspective: Cancer care and the new biology

      JOURNAL OF PATHOLOGY
    45. Fossa, SD; Stenning, SP; Gerl, A; Horwich, A; Clark, PI; Wilkinson, PM; Jones, WG; Williams, MV; Oliver, RT; Newlands, ES; Mead, GM; Cullen, MH; Kaye, SB; Rustin, GJS; Cook, PA
      Prognostic factors in patients progressing after cisplatin based chemotherapy for malignant non-seminomatous germ cell tumours

      BRITISH JOURNAL OF CANCER
    46. Evans, TRJ; Kaye, SB
      Retinoids: present role and future potential

      BRITISH JOURNAL OF CANCER
    47. Kaye, SB
      New drug development: its role in reversing drug resistance

      BRITISH JOURNAL OF CANCER
    48. Stroner, PL; Brewster, DH; Dewar, JA; Eremin, O; Gould, A; Howard, GC; Kaye, SB
      In pursuit of excellence for patients with cancer: the Scottish Cancer Therapy Network model

      BRITISH JOURNAL OF CANCER
    49. Collette, L; Sylvester, RJ; Stenning, SP; Fossa, SD; Mead, GM; de Wit, R; de Mulder, PHM; Neymark, N; Lallemand, E; Kaye, SB
      Impact of the treating institution on survival of patients with "poor-prognosis" metastatic nonseminoma

      JOURNAL OF THE NATIONAL CANCER INSTITUTE
    50. Anthoney, DA; Kaye, SB
      Drug resistance - The clinical perspective

      CYTOTOXIC DRUG RESISTANCE MECHANISMS
    51. MCDONALD AC; VASEY PA; ADAMS L; WALLING J; WOODWORTH JR; ABRAHAMS T; MCCARTHY S; BAILEY NP; SIDDIQUI N; LIND MJ; CALVERT AH; TWELVES CJ; CASSIDY J; KAYE SB
      A PHASE-I AND PHARMACOKINETIC STUDY OF LY231514, THE MULTITARGETED ANTIFOLATE

      Clinical cancer research
    52. MCDONALD AC; VASEY PA; ADAMS L; WALLING J; WOODWORTH JR; ABRAHAMS T; MCCARTHY S; BAILEY NP; SIDDIQUI N; LIND MJ; CALVERT AH; TWELVES CJ; CASSIDY J; KAYE SB
      A PHASE-I AND PHARMACOKINETIC STUDY OF LY231514, THE MULTITARGETED ANTIFOLATE

      Clinical cancer research
    53. SODER AI; GOING JJ; KAYE SB; KEITH WN
      TUMOR-SPECIFIC REGULATION OF TELOMERASE RNA GENE-EXPRESSION VISUALIZED BY IN-SITU HYBRIDIZATION

      Oncogene
    54. KAYE SB
      PRODRUGS OF 5-FU

      Annals of oncology
    55. PLUMB JA; KAYE SB
      THE PHOSPHOINOSITOL 3-KINASE INHIBITOR WORTMANNIN SENSITIZES MCF7 CELLS TO IONIZING-RADIATION AND TO THE TOPOISOMERASE-I INHIBITOR TOPOTECAN

      Annals of oncology
    56. NOONAN CP; RAO GP; KAYE SB; GREEN JR; CHANDNA A
      VALIDATION OF A HAND-HELD AUTOMATED KERATOMETER IN ADULTS

      Journal of cataract and refractive surgery
    57. KAYE SB; MEAD GM; FOSSA S; CULLEN M; DEWIT R; BODROGI I; VANGROENINGEN C; SYLVESTER R; COLLETTE L; STENNING S; DEPRIJCK L; LALLEMAND E; DEMULDER P
      INTENSIVE INDUCTION-SEQUENTIAL CHEMOTHERAPY WITH BOP VIP-B COMPARED WITH TREATMENT WITH BEP/EP FOR POOR-PROGNOSIS METASTATIC NONSEMINOMATOUS GERM-CELL TUMOR - A RANDOMIZED MEDICAL-RESEARCH-COUNCIL EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENT OF CANCER STUDY/

      Journal of clinical oncology
    58. FOSSA SD; KAYE SB; MEAD GM; CULLEN M; DEWIT R; BODROGI I; VANGROENINGEN CJ; DEMULDER PHM; STENNING S; LALLEMAND E; DEPRIJCK L; COLLETTE L
      FILGRASTIM DURING COMBINATION CHEMOTHERAPY OF PATIENTS WITH POOR-PROGNOSIS METASTATIC GERM-CELL MALIGNANCY

      Journal of clinical oncology
    59. BRUNO R; HILLE D; RIVA A; VIVIER N; HUINNINK WWTB; VANOOSTEROM AT; KAYE SB; VERWEIJ J; FOSSELLA FV; VALERO V; RIGAS JR; SEIDMAN AD; CHEVALLIER B; FUMOLEAU P; BURRIS HA; RAVCLIN PM; SHEINER LB
      POPULATION PHARMACOKINETICS PHARMACODYNAMICS OF DOCETAXEL IN PHASE-IISTUDIES IN PATIENTS WITH CANCER/

      Journal of clinical oncology
    60. CASSIDY J; PAUL J; SOUKOP M; HABESHAW T; REED NS; PARKIN D; KAYE SB
      CLINICAL-TRIALS OF NIMODIPINE AS A POTENTIAL NEUROPROTECTOR IN OVARIAN-CANCER PATIENTS TREATED WITH CISPLATIN

      Cancer chemotherapy and pharmacology
    61. PARMAR MKB; TORRI V; BONAVENTURA A; BONAZZI C; COLOMBO N; DELALOYE JF; MARSONI S; MANGIONI C; SANDERCOCK J; SESSA C; WILLIAMS C; TINAZZI A; FLANN M; GEISER K; SCORPIGLIONE N; STEWART JF; CHAVES J; PALMEIRO E; CURTAIN A; MCCORMACK T; GENNATAS C; MARRAS F; OPPO TG; BALESTRINO M; MALZONI C; MALZONI M; BELLI M; GEMINIANI ML; CRESTANI G; MONACO A; VAVALA V; PIATTO E; BARATTINI G; FORNARA PG; CHETRI MC; SANTEUFEMIA G; ARTIOLI F; CARONE D; FANIZZA G; TRENTADUE R; PRIOLO D; SCOLLO P; NIGRO SC; PETRINA M; MASTRANTONIO P; SPANNA GD; ZAGNI R; BELLONI C; COLLEONI R; REDAELLI L; CAVAGNINI A; DICOSTANZO G; PERRONI D; ARIENTI S; ORFANOTTI G; CANTONI FM; SECLI R; BIANCHI A; MARTINELLO R; MOLLICA G; MAIZZI D; PICCHIARELLI ME; FIORINI G; BORSANI M; COLOMBO E; GARSIA S; MELGRATI L; PAGGI G; BRUNENGHI GM; CASINI M; ISA L; ALGERI R; PROZIO G; BELFIORE G; ANGELINI F; DAPRILE M; MORESCHI M; MAURI ML; NATALE N; SENZANI FM; PAVANATO G; POGGI G; GARUTI G; LUERTI M; CRUCIANI G; PAGANO F; BACCOLO M; PODDI ER; BOCCIOLONE L; SABELLI MA; MAGGI R; RESTELLI C; DANTONA A; LOCATELLI MC; PESSI A; RAINA A; CHIARI S; GABRIELE A; PITTELLI MR; IACOBELLI P; DOGLIOTTI L; GORZEGNO G; MUSSO P; VEGNA G; COCO G; ALLETTI DG; PICCIOTTO F; LUCCHESE V; EPIS A; DIPALUMBO VS; DRUDI G; RAVAIOLI A; ZAMPELLA D; MORANDI MG; GORGA G; ZUCCHELLI C; CARIELLO S; GALLETTO L; SUSSIO M; MASSACESI L; MASSACESI M; CARLI A; TUCCI E; TAJANI E; CORRADO G; BUMMA S; DURANDO A; MASSOBRIO M; SBERVEGLIERI M; BIASIO M; GUERCIO E; JURA R; DANESE S; WIERDIS T; FARNELLI C; TARANTINO G; GRASSI R; REPETTI F; ROCCHI B; GRAMPA M; ERCOLI A; GRISO C; SIGNORI E; ZANINI L; PRESTI M; KLIMEK M; URBANSKI K; BISWAS A; VIEGAS O; KOCHLI O; DREHER E; FEY M; BECK G; LUDIN J; BONNEFOI H; KRAUER F; BAUER J; DELMORE G; FURRER C; LORENZ U; THURLIMANN B; LORENZ U; BRONZ L; SANNA P; WYSS D; GOLDHIRSCH A; GYR T; LEIDI L; PASTORELLI G; PAGANI O; REY P; HAILER U; BENZ J; KAYE SB; REED NS; SYMONDS RP; ATKINSON RJ; AXFORD AT; RUSTIN G; SECKL MJ; GREEN JA; SCOTT IV; GUTHRIE D; HARPER PG; CALMAN F; DOBBS HJ; WEIR P; CASSONI A; LEDERMAN JA; SOUHAMI RL; BOZZINO J; ADAB F; REDMAN CWE; SCOBLE JE; PATERSON M; DANIEL F; COWLEY N; WILLIAMS CJ; SPOONER D; HONG A; MCILLMURRAY M; HENDYIBBS P; HALL V; IVESON TJ; WHITEHOUSE JMA; GARRY R; LAMONT A; ROBINSON A; TRASK CW; CLUBB AW; MURRELL D; NEWMAN G; WILKINS M; GOLDTHORP WO; ROBERTS JK; RADSTONE DJ; WHIPP MJ; LEDERMANN JA; PATER J; BUYSE M; OMURA G
      ICON2 - RANDOMIZED TRIAL OF SINGLE-AGENT CARBOPLATIN AGAINST 3-DRUG COMBINATION OF CAP (CYCLOPHOSPHAMIDE, DOXORUBICIN, AND CISPLATIN) IN WOMEN WITH OVARIAN-CANCER

      Lancet
    62. SIMPSON AB; PAUL J; GRAHAM J; KAYE SB
      FATAL BLEOMYCIN PULMONARY TOXICITY IN THE WEST OF SCOTLAND 1991-95 - A REVIEW OF PATIENTS WITH GERM-CELL TUMORS

      British Journal of Cancer
    63. KAYE SB
      DRUG OR GENE-THERAPY FOR OVARIAN-CANCER - WHICH IS THE BEST HOPE FOR THE FUTURE

      British Journal of Cancer
    64. ADAMS M; CALVERT AH; CARMICHAEL J; CLARK PI; COLEMAN RE; EARL HM; GALLAGHER CJ; GANESAN TS; GORE ME; GRAHAM JD; HARPER PG; JAYSON GC; KAYE SB; LEDERMANN JA; OSBORNE RJ; PERREN TJ; POOLE CJ; RADFORD JA; RUSTIN GJS; SLEVIN ML; SMYTH JF; THOMAS H; WILKINSON PM
      CHEMOTHERAPY FOR OVARIAN-CANCER - A CONSENSUS STATEMENT ON STANDARD PRACTICE

      British Journal of Cancer
    65. AABO K; ADAMS M; ADNITT P; ALBERTS DS; ATHANAZZIOU A; BARLEY V; BELL DR; BIANCHI U; BOLIS G; BRADY MF; BRODOVSKY HS; BRUCKNER H; BUYSE M; CANETTA R; CHYLAK V; COHEN CJ; COLOMBO N; CONTE PF; CROWTHER D; EDMONSON JH; GENNATAS C; GILBEY E; GORE M; GUTHRIE D; KAYE SB; LAING AH; LANDONI F; LEONARD RC; LEWIS C; LIU PY; MANGIONI C; MARSONI S; MEERPOHL H; OMURA GA; PARMAR MKB; PATER J; PECORELLI S; PRESTI M; SAUERBREI W; SKARLOS DV; SMALLEY RV; SOLOMON HJ; STEWART LA; STURGEON JFG; TATTERSALL MHN; WHARTON JT; HUININK WWT; TOMIROTTI M; TORRI W; TROPE C; TURBOW MM; VERMORKEN JB; WEBB MJ; WILBUR DW; WILLIAMS CJ; WILTSHAW E; YEAP BY
      CHEMOTHERAPY IN ADVANCED OVARIAN-CANCER - 4 SYSTEMATIC METAANALYSES OF INDIVIDUAL PATIENT DATA FROM 39 RANDOMIZED TRIALS

      British Journal of Cancer
    66. DEWIT R; COLLETTE L; SYLVESTER R; DEMULDER PHM; SLEIJFER DT; HUININK WWT; KAYE SB; VANOOSTEROM AT; BOVEN E; STOTER G
      SERUM ALPHA-FETOPROTEIN SURGE AFTER THE INITIATION OF CHEMOTHERAPY FOR NONSEMINOMATOUS TESTICULAR CANCER HAS AN ADVERSE PROGNOSTIC-SIGNIFICANCE

      British Journal of Cancer
    67. KAYE SB
      NEW ANTIMETABOLITES IN CANCER-CHEMOTHERAPY AND THEIR CLINICAL IMPACT

      British Journal of Cancer
    68. KAYE SB
      NEW ANTIMETABOLITES IN CANCER-CHEMOTHERAPY AND THEIR CLINICAL IMPACT

      British Journal of Cancer
    69. MACKEAN MJ; MILLAN D; KAYE SB; BROWN R
      MISMATCH REPAIR PROTEIN IMMUNOHISTOCHEMISTRY IN OVARIAN-CANCER

      British Journal of Cancer
    70. KAYE SB; MORTON CE; TONG CYW; ODONNELL NP
      ECHOVIRUS KERATOCONJUNCTIVITIS

      American journal of ophthalmology
    71. SENAN S; RAMPLING R; GRAHAN MA; WILSON P; ROBIN H; ECKARDT N; LAWSON N; MCDONALD A; VONROEMELING R; WORKMAN P; KAYE SB
      PHASE-1 AND PHARMACOKINETIC STUDY OF TIRAPAZAMINE (SR-4233) ADMINISTERED EVERY 3 WEEKS (VOL 3, PG 31, 1997)

      Clinical cancer research
    72. SENAN S; RAMPLING R; GRAHAM MA; WILSON P; ROBIN H; ECKARDT N; LAWSON N; MCDONALD A; VONROEMELING R; WORKMAN P; KAYE SB
      PHASE-I AND PHARMACOKINETIC STUDY OF TIRAPAZAMINE (SR-4233) ADMINISTERED EVERY 3 WEEKS

      Clinical cancer research
    73. FOSSA SD; OLIVER RTD; STENNING SP; HORWICH A; WILKINSON P; READ G; MEAD GM; ROBERTS JT; RUSTIN G; CULLEN MH; KAYE SB; HARLAND SJ; COOK P
      PROGNOSTIC FACTORS FOR PATIENTS WITH ADVANCED SEMINOMA TREATED WITH PLATINUM-BASED CHEMOTHERAPY

      European journal of cancer
    74. DUCHESNE GM; STENNING SP; AASS N; MEAD GM; FOSSA SD; OLIVER RTD; HORWICH A; READ G; ROBERTS IT; RUSTIN G; CULLEN MH; KAYE SB; HARLAND SJ; COOK PA
      RADIOTHERAPY AFTER CHEMOTHERAPY FOR METASTATIC SEMINOMA - A DIMINISHING ROLE

      European journal of cancer
    75. KAYE SB; PICCART M; AAPRO M; FRANCIS P; KAVANAGH J
      PHASE-II TRIALS OF DOCETAXEL (TAXOTERE(R)) IN ADVANCED OVARIAN-CANCER- AN UPDATED OVERVIEW

      European journal of cancer
    76. ONEILL VJ; EVANS TRJ; KAYE SB
      AN AUDIT OF HICKMAN LINE COMPLICATIONS IN PATIENTS WITH SOLID TUMORS

      European journal of cancer
    77. WANDERS J; HUININK WWT; PAVLIDIS N; KAYE SB; SESSA C; LEHNERT M; PICCART M; PARIDAENS R; WISSEL P; HANAUSKE AR
      PHASE-II STUDIES WITH GI147211 (GI) IN BREAST (B), COLORECTAL (C) ANDNON-SMALL-CELL LUNG-CANCER (N)

      European journal of cancer
    78. KAYE SB
      MARINE ORGANISMS - ARE THEY A WORTHWHILE SOURCE

      European journal of cancer
    79. DETAKATS PG; DUNLOP D; KAYE SB; FYFE DW; BAKER P; PACCIARINI MA; VALOTA O; KERR DJ
      PHASE IB STUDY OF METHOXYMORPHOLINODOXORUBICIN (PNU-152243 FCE-23762)ADMINISTERED IN A 3 OR 4 WEEKLY SCHEDULE

      European journal of cancer
    80. CAPONIGRO F; FRENCH RC; KAYE SB
      PROTEIN-KINASE-C - A WORTHWHILE TARGET FOR ANTICANCER DRUGS

      Anti-cancer drugs
    81. KAYE SB; PATTERSON A
      ASSOCIATION BETWEEN TOTAL ASTIGMATISM AND MYOPIA

      Journal of cataract and refractive surgery
    82. DEWIT R; STOTER G; KAYE SB; SLEIJFER DT; JONES WG; HUININK WWT; REA LA; COLLETTE L; SYLVESTER R
      IMPORTANCE OF BLEOMYCIN IN COMBINATION CHEMOTHERAPY FOR GOOD-PROGNOSIS TESTICULAR NONSEMINOMA - A RANDOMIZED STUDY OF THE -ORGANIZATION-FOR-RESEARCH-AND-TREATMENT-OF-CANCER GENITOURINARY TRACT CANCER COOPERATIVE GROUP

      Journal of clinical oncology
    83. HORWICH A; SLEIJFER DT; FOSSA SD; KAYE SB; OLIVER RTD; CULLEN MH; MEAD GM; DEWIT R; DEMULDER PHM; DEARNALEY DP; COOK PA; SYLVESTER RJ; STENNING SP
      RANDOMIZED TRIAL OF BLEOMYCIN, ETOPOSIDE, AND CISPLATIN COMPARED WITHBLEOMYCIN, ETOPOSIDE, AND CARBOPLATIN IN GOOD-PROGNOSIS METASTATIC NONSEMINOMATOUS GERM-CELL CANCER - A MULTIINSTITUTIONAL MEDICAL-RESEARCH-COUNCIL -ORGANIZATION-FOR-RESEARCH-AND-TREATMENT-OF-CANCER TRIAL

      Journal of clinical oncology
    84. MEAD GM; STENNING SP; COOK P; FOSSA SD; HORWICH A; KAYE SB; OLIVER RTD; DEMULDER PHM; DEWIT R; STOTER G; SYLVESTER RJ; BAJORIN DF; BOSL GJ; MAZUMDAR M; NICHOLS CR; AMATO R; PIZZOCARO G; DROZ JP; KRAMAR A; DAUGAARD G; CORTESFUNES H; PAZARES L; LEVI JA; COLLS BM; HARVEY VJ; COPPIN C
      INTERNATIONAL GERM-CELL CONSENSUS CLASSIFICATION - A PROGNOSTIC FACTOR-ERASED STAGING SYSTEM FOR METASTATIC GERM-CELL CANCERS

      Journal of clinical oncology
    85. AAMDAL S; BRUNTSCH U; KERGER J; VERWEIJ J; HUININK WT; WANDERS J; RASTOGI R; FRANKLIN HR; KAYE SB
      ZENIPLATIN IN ADVANCED MALIGNANT-MELANOMA AND RENAL-CANCER - PHASE-IISTUDIES WITH UNEXPECTED NEPHROTOXICITY

      Cancer chemotherapy and pharmacology
    86. GRAHAM MA; SENAN S; ROBIN H; ECKHARDT N; LENDREM D; HINCKS J; GREENSLADE D; RAMPLING R; KAYE SB; VONROEMELING R; WORKMAN P
      PHARMACOKINETICS OF THE HYPOXIC CELL CYTOTOXIC AGENT TIRAPAZAMINE ANDITS MAJOR BIOREDUCTIVE METABOLITES IN MICE AND HUMANS - RETROSPECTIVEANALYSIS OF A PHARMACOKINETICALLY GUIDED DOSE-ESCALATION STRATEGY IN A PHASE-I TRIAL

      Cancer chemotherapy and pharmacology
    87. KAYE SB; LAGNADO R; MORTON CE; KAYE DB
      ATRAUMATIC TRANSFER OF THE DONOR CORNEAL BUTTON

      Cornea
    88. SCOTT JA; HOWARD PJ; SMITH PA; FRYER A; EASTY DL; PATTERSON A; KAYE SB
      HISTOPATHOLOGY AND MOLECULAR CYTOGENETICS OF A CORNEAL OPACITY ASSOCIATED WITH THE TRISOMY-8 MOSAIC SYNDROME (46,XY 47,XY,+8)/

      Cornea
    89. FIELD EA; LONGMAN LP; BUCKNALL R; KAYE SB; HIGHAM SM; EDGAR WM
      THE ESTABLISHMENT OF A XEROSTOMIA CLINIC - A PROSPECTIVE-STUDY

      British journal of oral & maxillofacial surgery
    90. KAYE SB; ODONNELL N; HOLDEN R
      RECORDING SENSORY AND MOTOR ASPECTS OF STRABISMUS

      Journal of pediatric ophthalmology and strabismus
    91. KAYE SB; SIDDIQUI A; WARD A; NOONAN C; FISHER T; BROWN M
      A VARIABLE DISTANCE STEREOACUITY TEST

      Investigative ophthalmology & visual science
    92. LONGMAN JP; HIGHAM SM; BUCKNALL R; KAYE SB; EDGAR WM; FIELD EA
      SIGNS AND SYMPTOMS IN PATIENTS WITH SALIVARY-GLAND HYPOFUNCTION

      Postgraduate medical journal
    93. VASEY PA; KAYE SB
      COMBINED INHIBITION OF TOPOISOMERASE-I AND TOPOISOMERASE-II - IS THISA WORTHWHILE FEASIBLE STRATEGY/

      British Journal of Cancer
    94. DEWIT R; SYLVESTER R; TSITSA C; DEMULDER PHM; SLEYFER DT; HUININK WWT; KAYE SB; VANOOSTEROM AT; BOVEN E; VERMEYLEN K; STOTER G
      TUMOR-MARKER CONCENTRATION AT THE START OF CHEMOTHERAPY IS A STRONGERPREDICTOR OF TREATMENT FAILURE THAN MARKER HALF-LIFE - A STUDY IN PATIENTS WITH DISSEMINATED NONSEMINOMATOUS TESTICULAR CANCER

      British Journal of Cancer
    95. KAYE SB; MORTON CE; NEEDHAM A; SCOTT JA; WATSON A; HISCOTT P
      SUPERIOR TARSAL CONJUNCTIVAL BULLAE IN CICATRICIAL PEMPHIGOID

      American journal of ophthalmology
    96. KAYE SB
      MULTIDRUG-RESISTANCE IN BREAST-CANCER - IS THE JURY IN YET

      Journal of the National Cancer Institute
    97. LOPEZ RI; PAUL J; ATKINSON R; SOUKOP M; KITCHENER H; FULLERTON W; DUNCAN I; KENNEDY J; DAVIS J; MACLEAN A; CASSIDY J; PYPER E; KAYE SB
      PROGNOSTIC FACTOR-ANALYSIS, FOR PATIENTS WITH NO EVIDENCE OF DISEASE AFTER INITIAL CHEMOTHERAPY FOR ADVANCED EPITHELIAL OVARIAN-CARCINOMA

      International journal of gynecological cancer
    98. BISSETT D; HARNETT AN; CANNEY PA; MCMURRAY A; LEAKE R; GEORGE WD; PAUL J; KAYE SB
      SEQUENTIAL TAMOXIFEN AND MEGESTROL-ACETATE WITH CONTINUOUS NORETHISTERONE IN POSTMENOPAUSAL BREAST-CANCER - A FEASIBILITY STUDY

      Breast
    99. HUGHES MJ; KERR DJ; CASSIDY J; SOUKOP M; MCGREGOR K; BLACKBURN N; YOSEF H; KAYE SB
      A PILOT-STUDY OF COMBINATION THERAPY WITH INTERFERON-ALPHA-2A AND 5-FLUOROURACIL IN METASTATIC CARCINOID AND MALIGNANT ENDOCRINE PANCREATICTUMORS

      Annals of oncology
    100. KAYE SB
      OVARIAN-CANCER, FROM THE LABORATORY TO THE CLINIC - CHALLENGES FOR THE FUTURE - ESMO-AWARD-LECTURE, ECCO-8 PARIS, 28 OCTOBER TO 2 NOVEMBER 1995

      Annals of oncology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 26/01/21 alle ore 14:30:06